Recent news
and insights
ESMO OncologyPRO resource on PARP inhibition and DNA Damage response (DDR)
Information on PARP inhibition and DNA Damage Response (DDR) as therapeutic targets across multiple tumour types.
Understand the mechanism of action of PARP inhibitors and targeting DNA Damage Response (DDR): A short video
This short video succinctly explains the concept of DDR, including the role of Homologous Recombination Repair (HRR) in DNA repair and the impact of BRCA1 and BRCA2 mutations
Educational Programmes on DNA Damage Response (DDR) and PARP inhibition in Oncology
These educational programmes enable healthcare professionals around the world to increase their understanding of DDR and PARP inhibition and provide the best possible care to their patients.
Drug-Drug Interactions with Kinase Inhibitors
Understand the clinically relevant drug-drug interactions with kinase inhibitors.
The role of DDR and PARP inhibition (PARPi) in oncology
A variety of topics are covered, including the role of DDR in oncology, synthetic lethality, use of PARPi in oncology, efficacy and safety of currently approved PARP inhibitors, and the role of combination therapy with PARPi.
Improving management through genetic testing for Familial Hypercholesterolaemia (FH)
This e-learning course addresses a need for improved understanding of the diagnosis and management of Familial Hypercholesterolaemia (FH), particularly through the use of genetic testing.
The CONNECTs News
-
NET CONNECT Update from ENETS 2020
-
Treating mCRPC patients who have progressed on AR-directed therapy
-
GI CONNECT e-learning on the impact of key CRC data on sequential clinical practice
-
SARCOMA CONNECT: Highlights from ESMO Sarcoma and GIST 2020
-
LYMPHOMA CONNECT Experts Knowledge Share ASH 2019
-
Event 1: Bambino Gesù Children’s Hospital, January 2020
-
HCC CONNECT e-learning with important new data on treatment sequencing in advanced HCC
-
NTRK gene fusions, TRK inhibitors and testing approaches BluePrint
-
The GUIDE Communication Framework
-
Update from ESMO 2019